- Home
- FCO vs VRCA Comparison
FCO vs VRCA Comparison
Compare FCO & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FCO | VRCA |
|---|---|---|
| Founded | 1991 | 2013 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.4M | 32.7M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | FCO | VRCA |
|---|---|---|
| Price | $2.97 | $8.98 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 100.1K | ★ 359.1K |
| Earning Date | 01-01-0001 | 11-14-2025 |
| Dividend Yield | ★ 14.96% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.43 | N/A |
| Revenue | N/A | ★ $30,829,000.00 |
| Revenue This Year | N/A | $332.45 |
| Revenue Next Year | N/A | $12.85 |
| P/E Ratio | $12.30 | ★ N/A |
| Revenue Growth | N/A | ★ 234.73 |
| 52 Week Low | $4.73 | $3.28 |
| 52 Week High | $6.63 | $12.50 |
Technical Indicators
Market Signals| Indicator | FCO | VRCA |
|---|---|---|
| Relative Strength Index (RSI) | 45.52 | 72.36 |
| Support Level | $2.89 | $6.26 |
| Resistance Level | $3.02 | $9.82 |
| Average True Range (ATR) | 0.07 | 0.97 |
| MACD | 0.02 | 0.44 |
| Stochastic Oscillator | 60.14 | 86.39 |
Price Performance
Historical ComparisonAbout FCO abrdn Global Income Fund Inc.
abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories, Developed Markets, Investment Grade Developing Markets and Sub-Investment Grade Developing Markets.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.